SB reduced the serum concentrations of tumor necrosis factor alpha (TNF-α), IL-1β, IL-6, and IL-4 in animals with MASLD [24,26]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.